REFERENCES
- Shah CP, McKey J, Spirn MJ, Maguire J. Ocular candidiasis: a review. British J Ophthalmol. 2008;92(4):466–468. doi:10.1136/bjo.2007.133405.
- Sallam A, Taylor SRJ, Khan A, et al. FACTORS DETERMINING VISUAL OUTCOME IN ENDOGENOUS CANDIDA ENDOPHTHALMITIS. Retina. 2012;32(6):1129–1134. doi:10.1097/IAE.0b013e31822d3a34.
- Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of Candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis. December 2015;civ933. doi:10.1093/cid/civ933.
- Shen X, Xu G. Vitrectomy for endogenous fungal endophthalmitis. Ocul Immunol Inflamm. 2009;17(3):148–152. doi:10.1080/09273940802689396.
- Louie A, Liu W, Miller DA, et al. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans. Antimicrob Agents Chemother. 1999;43(12):2831–2840.
- Tod M, Lortholary O, Padoin C, Chaine G. Intravenous penetration of fluconazole during endophthalmitis. Clin Microbiol Infect. 1997;3:143–144.
- Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the treatment of fungal eye infections: a review of current literature. British J Ophthalmol. 2008;92(7):871–878. doi:10.1136/bjo.2007.136515.
- Kinoshita J, Iwata N, Ohba M, Kimotsuki T, Yasuda M. Mechanism of voriconazole-induced transient visual disturbance: reversible dysfunction of retinal ON-bipolar cells in monkeys. Invest Ophthalmol Vis Sci. 2011;52(8):5058–5063. doi:10.1167/iovs.11-7183.
- Kernt M, Neubauer AS, De Kaspar HM, Kampik A. Intravitreal voriconazole: in vitro safety-profile for fungal endophthalmitis. Retina (Philadelphia, Pa). 2009;29(3):362–370. doi:10.1097/IAE.0b013e31818d4b9b.
- Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol. 2005;139(1):135–140. doi:10.1016/j.ajo.2004.08.077.
- Lin RC, Sanduja N, Hariprasad SM. Successful treatment of postoperative fungal endophthalmitis using intravitreal and intracameral voriconazole. J Ocul Pharmacol Ther. 2008;24(2):245–248. doi:10.1089/jop.2007.0105.
- Landré C, Baillif S. Endophtalmies endogènes bactériennes et fongiques au CHU de Nice : revue des cas sur 15ans. J Fr Ophtalmol. 2016;39(4):346–354. doi:10.1016/j.jfo.2015.11.007.
- Pierce J, Warrier N, Antonopoulos C, Siegel N, Husain D. Iris abscess a rare presentation of intravenous drug abuse associated Candida endophthalmitis. Am J Ophthalmol Case Rep. 2016;4:27–29. doi:10.1016/j.ajoc.2016.07.003.
- Durand ML. Bacterial and Fungal Endophthalmitis. Clin Microbiol Rev. 2017;30(3):597–613. doi:10.1128/CMR.00113-16.